Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zicam Immune Support is an over-the-counter dietary supplement developed and marketed by Church & Dwight Co., Inc. following its acquisition of Matrixx Initiatives in 2020. Launched in July 2022, the product is formulated as citrus strawberry flavored gummies designed for daily use to support general immune system health and wellness. Each serving provides 100% of the daily value of three key nutrients: zinc, vitamin C, and vitamin D. Unlike Zicam's traditional zinc-based cold-shortening products, this supplement is positioned for proactive daily maintenance rather than reactive treatment of cold symptoms. As a dietary supplement, it is not intended to diagnose, treat, cure, or prevent any disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zicam Immune Support.